Trial
NCT01769885
Tivozanib Before Surgery in Treating Patients With Localized Kidney Cancer
UnknownWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Roswell Park Cancer Institute
Collaborators
AVEO Pharmaceuticals, Inc.
Condition
Stage II Renal Cell Cancer
Intervention
tivozanib
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-08-15